Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$132M |
| 2 |
Newmont
NEM
|
+$67.7M |
| 3 |
Corteva
CTVA
|
+$65.9M |
| 4 |
Amcor
AMCR
|
+$58.2M |
| 5 |
Alibaba
BABA
|
+$48.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Apple
AAPL
|
+$93M |
| 3 |
GG
Goldcorp Inc
GG
|
+$78.3M |
| 4 |
Microsoft
MSFT
|
+$73.5M |
| 5 |
Pfizer
PFE
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 11.95% |
| 4 | Communication Services | 10.15% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Plug Power
PLUG
$2.94B
| $977K | ﹤0.01% |
434,200
+8,900
| +2% | +$22.1K |
|
2127
Cytokinetics
CYTK
$10.5B
| $974K | ﹤0.01% |
86,600
+4,500
| +5% | +$43.4K |
|
2128
QCR Holdings
QCRH
$1.7B
| $971K | ﹤0.01% |
27,839
+700
| +3% | +$23.8K |
|
2129
Talos Energy
TALO
$2.6B
| $969K | ﹤0.01% |
40,300
+800
| +2% | +$20.9K |
|
2130
National Beverage
FIZZ
$2.91B
| $968K | ﹤0.01% |
43,400
+1,000
| +2% | +$25.7K |
|
2131
Intellia Therapeutics
NTLA
$1.68B
| $964K | ﹤0.01% |
58,900
+16,400
| +39% | +$258K |
|
|
GTS
2132
DELISTED
Triple-S Management Corporation
GTS
| $964K | ﹤0.01% |
42,465
| – | – |
|
|
CPLG
2133
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $963K | ﹤0.01% |
77,750
+1,700
| +2% | +$21.5K |
|
2134
Forrester Research
FORR
$221M
| $957K | ﹤0.01% |
20,350
+2,100
| +12% | +$101K |
|
2135
Fossil Group
FOSL
$317M
| $956K | ﹤0.01% |
83,141
+2,000
| +2% | +$24.6K |
|
|
CTT
2136
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $955K | ﹤0.01% |
91,418
+2,100
| +2% | +$20.9K |
|
|
MITT
2137
TPG Mortgage Investment Trust
MITT
$201M
| $952K | ﹤0.01% |
19,967
+667
| +3% | +$32.9K |
|
|
RVNC
2138
DELISTED
Revance Therapeutics, Inc.
RVNC
| $951K | ﹤0.01% |
73,350
+3,900
| +6% | +$49.2K |
|
|
RVI
2139
DELISTED
Retail Value Inc. Common Shares
RVI
| $951K | ﹤0.01% |
297,646
-6,537
| -2% | -$20.1K |
|
|
PGNX
2140
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $951K | ﹤0.01% |
154,100
| – | – |
|
|
VSTO
2141
DELISTED
Vista Outdoor Inc.
VSTO
| $951K | ﹤0.01% |
107,100
+2,100
| +2% | +$18K |
|
2142
Republic Bancorp
RBCAA
$1.91B
| $950K | ﹤0.01% |
19,100
+500
| +3% | +$23.6K |
|
|
FLIC
2143
DELISTED
First of Long Island Corp
FLIC
| $949K | ﹤0.01% |
47,250
+3,100
| +7% | +$68.5K |
|
2144
Buckle
BKE
$2.4B
| $947K | ﹤0.01% |
54,700
+1,100
| +2% | +$19.3K |
|
|
FFWM
2145
DELISTED
First Foundation Inc
FFWM
| $945K | ﹤0.01% |
70,300
+9,500
| +16% | +$131K |
|
|
CORR
2146
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $944K | ﹤0.01% |
+23,800
| New | +$927K |
|
|
VRAY
2147
DELISTED
ViewRay, Inc.
VRAY
| $942K | ﹤0.01% |
106,900
+11,000
| +11% | +$89.3K |
|
2148
CytomX Therapeutics
CTMX
$750M
| $941K | ﹤0.01% |
83,900
+6,000
| +8% | +$62.9K |
|
2149
Bank of Marin Bancorp
BMRC
$455M
| $939K | ﹤0.01% |
22,900
| – | – |
|
|
VIVO
2150
DELISTED
Meridian Bioscience Inc
VIVO
| $939K | ﹤0.01% |
79,000
+1,700
| +2% | +$20.5K |
|
Similar funds
Swiss National Bank's Q2 2019 Portfolio in Review
As of Q2 2019, Swiss National Bank held 2,619 positions worth $92.7B, up 1.7% from $91.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Swiss National Bank's Q2 2019 filing shows 112 new, 1,554 increased, 696 reduced and 65 closed positions. Its largest new stake was Dow Inc: 2,494,044 shares worth $123M. The largest sale was DuPont de Nemours, an estimated $128M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2019 buy was Dow Inc: 2,494,044 shares worth $123M.
- Swiss National Bank added most to Newmont in Q2 2019, an estimated $67.7M increase.
- Swiss National Bank's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $128M.
- Swiss National Bank fully exited Goldcorp Inc in Q2 2019, selling an estimated $78.3M.
- Swiss National Bank's ten largest holdings make up 18% of its $92.7B portfolio in Q2 2019.
- Swiss National Bank opened 112 new positions and closed 65 in Q2 2019.
- Swiss National Bank's portfolio value rose 1.7% quarter-over-quarter to $92.7B.
Based on Swiss National Bank's 13F filing for Q2 2019, filed 2 Aug 2019.